Rusnano Of Russia To Invest $40.5 Million In Pharma Facility
This article was originally published in PharmAsia News
Executive Summary
Russia’s Rusnano, an investor in nanotechnology, said it would put $40.5 million into a Kirov pharmaceutical facility dedicated to producing nano-carriers.